Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04560556 · ClinicalTrials.gov registry record
Linking Persons With HIV, Discharged From Jail, With Community Care
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 122
- Enrollment target
NCT04560556: Completed study, sponsored by Emory University.
NCT04560556 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 122 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04560556 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
Study Summary
This is a prospective cohort study of outcomes of individuals who entered jail during a period during which one of three serial HIV testing strategies is implemented. This study involves two sub-studies. One sub-study will examine referrals to HIV prevention programs for persons testing negative for HIV while in jail. The second sub-study will monitor antiviral use among those testing positive for HIV.
Primary Outcome
The number of entrants receiving an HIV test within 24 hours of intake will be examined.
Interventions
- DIAGNOSTIC_TEST Point-of-Care (POC) Rapid HIV Test
- DIAGNOSTIC_TEST Fourth Generation Antigen/antibody (Ag/Ab) HIV Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2021-11-24 |
What the finished NCT04560556 record still lists
NCT04560556 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Point-of-Care (POC) Rapid HIV Test is the first listed.
NCT04560556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04560556 about?
NCT04560556 is a clinical study titled "Linking Persons With HIV, Discharged From Jail, With Community Care". This is a prospective cohort study of outcomes of individuals who entered jail during a period during which one of three serial HIV testing strategies is implemented. This study involves two sub-studies. One sub-study will examine referrals to HIV prevention programs for persons testing negative for...
What is the current status of trial NCT04560556?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2020-11-10. Estimated completion is 2021-11-24.
What interventions are being tested in trial NCT04560556?
The interventions under investigation include: Point-of-Care (POC) Rapid HIV Test (DIAGNOSTIC_TEST), Fourth Generation Antigen/antibody (Ag/Ab) HIV Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04560556?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI